Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.
about
Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolismSoluble epoxide hydrolase: A potential target for metabolic diseasesArg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humansEpoxyeicosatrienoic acids and glucose homeostasis in mice and menThe 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic painAnti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal UlcersInhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in micePhenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activityA diet containing a nonfat dry milk matrix significantly alters systemic oxylipins and the endocannabinoid 2-arachidonoylglycerol (2-AG) in diet-induced obese miceFunctional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity.Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxidesEffects of soluble epoxide hydrolase deficiency on acute pancreatitis in miceEndoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain.Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice.Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosisModulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic DiseasesLipidomic profiling of high-fat diet-induced obesity in mice: Importance of cytochrome P450-derived fatty acid epoxides.Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.Docosahexaenoic Acid in Combination with Dietary Energy Restriction for Reducing the Risk of Obesity Related Breast Cancer.Mangiferin suppresses endoplasmic reticulum stress in perivascular adipose tissue and prevents insulin resistance in the endothelium.Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation.Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease
P2860
Q28245279-FECE59DE-41E4-4949-B2FE-C51E086057EAQ28270454-BDCC637E-3647-4839-8996-5636071CD9E4Q28383458-5D7C4634-6445-43B3-A647-F6F0A74FF030Q28390016-10AA17F7-F370-40D1-A4B1-5B85E9FDEFB5Q28392416-17F1A678-1092-4241-B11B-FF8A65A29931Q28395478-70A6C0DD-03C4-482D-9F39-E13C6B710C99Q28395856-8B766D36-B99A-43DB-8C87-1AA98D699836Q28822090-3CDEBDD8-F293-4835-A315-E1DA8601799AQ33799861-1CC91AE6-43C4-4054-8A95-959C361CDB4DQ34238703-AF38ECED-DF2A-4D8E-94E7-E5A5F07DB15FQ34774458-C1DB9C09-0DB0-40F0-9C50-67A26929F48FQ34985408-7B0B33D8-1046-445C-9874-93F191478E1FQ35427989-1CC38C6C-261E-422E-9625-7F5CA211E81CQ35895730-45CD10C4-27A0-40A7-9482-204BD82B5A6DQ35897881-1AB4B72B-70DA-4E42-9302-1023DFFE3752Q35923589-7A8B6728-457B-48AF-AC43-38F3D49575AFQ38605323-C213BC0A-D86D-4A51-BA88-920C1CE9FA81Q38763928-35DC1BE5-8B91-4FA9-B539-DD18D8C6D111Q39788692-5066F120-22F0-4032-8F1B-44EDF2709898Q40273110-0D55492C-0AA9-44D0-B005-3CE458FEC433Q41172019-7622F365-4778-424F-B843-EF59FBCEF2FCQ45976996-FF47B378-C341-419F-A446-03EC19E3E341Q46877188-7F123949-ABD1-47D1-8784-AACDED7A7C5CQ48045599-1B9646AD-3280-4B21-9698-6EBA90B5458FQ50667640-80A16D25-CC15-47C6-AD38-495FC34F0AE3Q53069744-DF1E6CC4-5807-42E5-992B-839DA65C7DD4Q58695979-F829FB1B-97F6-4F29-8B1C-94CD82888552
P2860
Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Soluble epoxide hydrolase defi ...... s in liver and adipose tissue.
@en
type
label
Soluble epoxide hydrolase defi ...... s in liver and adipose tissue.
@en
prefLabel
Soluble epoxide hydrolase defi ...... s in liver and adipose tissue.
@en
P2093
P2860
P356
P1476
Soluble epoxide hydrolase defi ...... ss in liver and adipose tissue
@en
P2093
Ahmed Bettaieb
Bruce D Hammock
Christophe Morisseau
Daniel AbouBechara
Fawaz G Haj
Samah Chahed
P2860
P304
14189-14199
P356
10.1074/JBC.M113.458414
P407
P50
P577
2013-04-10T00:00:00Z